Skip to content

COBRA APOTHEEK CENTRUM: what changed

BE 0439.260.144NACE 47.730, Retail sale of pharmaceutical productsOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€76,700
2024 · €42,176+€34,524
Equity
€321,578
2024 · €279,878+€41,700
Cash
€158,295
2024 · €137,663+€20,633
Balance sheet total
€791,276
2024 · €722,345+€68,931

Largest movements

2024 to 2025
Assets
  • Receivables within one year +€44,825

    up €44,825 (+21.9%), from €204,565 to €249,391

    of which Trade receivables: +€41,046

  • Tangible fixed assets -€29,516

    down €29,516 (-18.0%), from €163,641 to €134,125

    of which Land and buildings: -€16,787

  • Deferred charges and accrued income +€22,491

    up €22,491 (+101%), from €22,363 to €44,854

  • Cash +€20,633

    up €20,633 (+15.0%), from €137,663 to €158,295

    mainly Net result for the year (+€76,700) and Trade debts (+€55,640)

  • Stocks and contracts +€10,498

    up €10,498 (+5.4%), from €194,113 to €204,611

Equity and liabilities
  • Trade debts +€55,640

    up €55,640 (+33.5%), from €166,260 to €221,900

  • Reserves +€40,000

    up €40,000 (+36.7%), from €109,000 to €149,000

  • Debts after one year -€18,365

    down €18,365 (-11.9%), from €154,758 to €136,393

  • Current portion of long-term debt -€17,487

    down €17,487 (-48.8%), from €35,852 to €18,365

  • Other debts +€10,834

    up €10,834 (+21.4%), from €50,579 to €61,413

Income statement
  • Gross operating margin +€32,142

    up €32,142 (+10.7%), from €300,174 to €332,315

  • Depreciation -€9,392

    down €9,392 (-21.5%), from €43,733 to €34,340

  • Staff costs +€4,520

    up €4,520 (+2.3%), from €195,033 to €199,553

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €42,176
Gross operating margin +€32,142
Staff costs -€4,520
Depreciation +€9,392
Other operating charges +€740
Financial income -€3,265
Financial charges -€167
Taxes +€202
Result 2025 €76,700
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€96,153
Investment -€4,824
Financing -€70,696
Cash 2024 €137,663
Net result for the year +€76,700
Depreciation +€34,340
Stocks and contracts -€10,498
Receivables within one year -€44,825
Deferred charges and accrued income -€22,491
Trade debts +€55,640
Tax, wage and social debts -€3,547
Other debts +€10,834
Investment in fixed assets (net) -€4,824
Debts after one year -€18,365
Current portion of long-term debt -€17,487
Short-term financial debts +€156
Contributions, distributions and other -€35,000
Cash 2025 €158,295
brings cash intakes cash out
Every line side by side 47 lines
Line Code 2024 2025 Change %
Total assets 20/58 €722,345 €791,276 +€68,931 +9.5%
Fixed assets 21/28 €163,641 €134,125 -€29,516 -18.0%
Tangible fixed assets 22/27 €163,641 €134,125 -€29,516 -18.0%
Land and buildings 22 €136,037 €119,250 -€16,787 -12.3%
Plant, machinery and equipment 23 €26,838 €12,324 -€14,515 -54.1%
Furniture and vehicles 24 €766 €2,551 +€1,786 +233%
Current assets 29/58 €558,704 €657,152 +€98,447 +17.6%
Stocks and contracts in progress 3 €194,113 €204,611 +€10,498 +5.4%
Stocks 30/36 €194,113 €204,611 +€10,498 +5.4%
Amounts receivable within one year 40/41 €204,565 €249,391 +€44,825 +21.9%
Trade receivables 40 €91,525 €132,572 +€41,046 +44.8%
Other amounts receivable 41 €113,040 €116,819 +€3,779 +3.3%
Cash at bank and in hand 54/58 €137,663 €158,295 +€20,633 +15.0%
Deferred charges and accrued income 490/1 €22,363 €44,854 +€22,491 +101%
Total equity and liabilities 10/49 €722,345 €791,276 +€68,931 +9.5%
Equity 10/15 €279,878 €321,578 +€41,700 +14.9%
Contributions 10/11 €168,550 €168,550 = 0.0%
Reserves 13 €109,000 €149,000 +€40,000 +36.7%
Distributable reserves 133 €109,000 €149,000 +€40,000 +36.7%
Profit (loss) carried forward 14 €2,328 €4,028 +€1,700 +73.1%
Amounts payable 17/49 €442,467 €469,698 +€27,231 +6.2%
Amounts payable after more than one year 17 €154,758 €136,393 -€18,365 -11.9%
Financial debts 170/4 €154,758 €136,393 -€18,365 -11.9%
Amounts payable within one year 42/48 €287,709 €333,305 +€45,596 +15.8%
Current portion of amounts payable after more than one year 42 €35,852 €18,365 -€17,487 -48.8%
Financial debts 43 €2,724 €2,880 +€156 +5.7%
Credit institutions 430/8 €2,724 €2,880 +€156 +5.7%
Trade debts 44 €166,260 €221,900 +€55,640 +33.5%
Suppliers 440/4 €166,260 €221,900 +€55,640 +33.5%
Taxes, remuneration and social security 45 €32,295 €28,748 -€3,547 -11.0%
Taxes 450/3 €3,963 €3,936 -€27 -0.7%
Remuneration and social security 454/9 €28,331 €24,812 -€3,519 -12.4%
Other amounts payable 47/48 €50,579 €61,413 +€10,834 +21.4%
Accrued charges and deferred income 492/3 €0 - =
Remuneration, social security and pensions 62 €195,033 €199,553 +€4,520 +2.3%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €43,733 €34,340 -€9,392 -21.5%
Other operating charges 640/8 €4,240 €3,500 -€740 -17.5%
Gross operating margin 9900 €300,174 €332,315 +€32,142 +10.7%
Operating profit (loss) 9901 €57,168 €94,922 +€37,754 +66.0%
Financial income 75/76B €5,743 €2,477 -€3,265 -56.9%
Recurring financial income 75 €5,743 €2,477 -€3,265 -56.9%
Financial charges 65/66B €5,887 €6,054 +€167 +2.8%
Recurring financial charges 65 €5,887 €6,054 +€167 +2.8%
Profit (loss) for the period before taxes 9903 €57,023 €91,345 +€34,322 +60.2%
Income taxes 67/77 €14,847 €14,645 -€202 -1.4%
Profit (loss) for the period 9904 €42,176 €76,700 +€34,524 +81.9%
Profit (loss) for the period to be appropriated 9905 €42,176 €76,700 +€34,524 +81.9%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€393,207 to €486,174

Midpoint €431,943 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years earnings weight 50%

Adjusted equity €321,578
Capitalised earnings €464,836 to €650,770
Indication €393,207 to €486,174

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€321,578
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€321,578

Capitalised earnings

net result for the year (9904)
2025
€76,700
2024
€42,176
2023
€76,355
2022
€47,993
2021
€37,862
Average result
€65,077
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€464,836 / €542,308 / €650,770

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 14 November 2026 via checked.be.